Shijiazhuang Hipro Biotechnology Co., Ltd. · Class II · Cleared Sep 12, 2024
| K-number | K220999 |
| Device name | Hipro Glycosylated Hemoglobin (HbA1c) Test System |
| Applicant | Shijiazhuang Hipro Biotechnology Co., Ltd. |
| Product code | PDJ |
| Device class | Class II |
| Decision date | Sep 12, 2024 |
| Decision | Substantially Equivalent |
| Regulation | 862.1373 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov